Prof. Claire Harrison has been honored with the 2026 EHA Lifetime Achievement Award, recognizing her exceptional contributions to hematology and her lasting influence on the care of patients with myeloproliferative neoplasms.
The European Hematology Association announced the 2026 EHA Award winners, celebrating clinicians, researchers, mentors, and emerging leaders whose work continues to advance hematology worldwide. The awards highlight excellence across clinical practice, scientific discovery, education, mentorship, diversity, equity, inclusion, and leadership.
A Life Dedicated to Myeloproliferative Neoplasms
Prof Claire Harrison receives the EHA Lifetime Achievement Award for her extensive academic work, leadership in clinical trials, and strong commitment to patient advocacy.
Her career has been closely linked to major progress in the understanding and treatment of myeloproliferative neoplasms. Through prolific and practice-changing academic contributions, she has helped shape the way these diseases are studied, treated, and discussed within the hematology community.
With more than 300 publications and multiple prestigious recognitions, Prof Claire Harrison stands as one of the leading voices in the field. Her work has influenced clinical practice, supported the development of new treatment strategies, and contributed to a deeper scientific understanding of hematologic disease.
Leadership Beyond Research
Prof Claire Harrison’s impact extends beyond academic medicine. She has played an important role in clinical trial leadership, helping drive studies that have contributed to progress in hematology and improved standards of care.
Her influence is also deeply felt in patient advocacy. As co-founder of MPN Voice and trustee of Blood Cancer UK, she has helped strengthen the connection between scientific progress, clinical practice, and the lived experience of patients.
This patient-centered approach has become a defining feature of her career. Her recognition by EHA reflects not only scientific achievement, but also a commitment to keeping patients at the heart of hematology.
An Inspiring Mentor and Leader
EHA also recognized Prof Claire Harrison as an inspiring and approachable mentor. Throughout her career, she has supported the development of future hematology leaders, combining academic excellence with clarity, collaboration, and compassion.
Her leadership has influenced colleagues, trainees, researchers, and patient communities, making her contribution both scientific and human.
EHA Awards 2026: Honoring Excellence Across Hematology
The 2026 EHA Awards recognize individuals whose work has transformed patient care, scientific understanding, and professional development across hematology.
The award recipients were selected through an independent process involving the EHA Board, Young EHA, the Patient Advocacy Committee, and the Diversity, Equity, and Inclusion Taskforce.
Alongside Prof Claire Harrison , the 2026 awardees include leaders recognized for clinical excellence, research excellence, education and mentoring, diversity and inclusion, and early-career achievements.
A Moment of Recognition at EHA 2026
Each year, the EHA Annual Congress brings together hematology professionals from around the world for scientific exchange, collaboration, and community. In 2026, EHA will honor the award recipients live on stage, celebrating their achievements before an international audience of peers, partners, and future innovators.
For Prof Harrison, the Lifetime Achievement Award marks a powerful recognition of a career dedicated to advancing hematology, improving patient care, and strengthening the voice of patients within the field.
Discover more articles like this on OncoDaily
Written by Nare Hovhannisyan, MD